BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aroldi F, Bertocchi P, Savelli G, Rosso E, Zaniboni A. Pancreatic cancer: New hopes after first line treatment. World J Gastrointest Oncol 2016; 8(9): 682-687 [PMID: 27672426 DOI: 10.4251/wjgo.v8.i9.682]
URL: https://www.wjgnet.com/1948-5204/full/v8/i9/682.htm
Number Citing Articles
1
Elisabetta Malangone-Monaco, Yunes Doleh, Ashley Cole, Virginia Noxon, Giovanni Antico, Michael J. Pishvaian. The economic burden of metastatic pancreatic cancerPancreatology 2020; 20(7): 1434 doi: 10.1016/j.pan.2020.09.002
2
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti. Drug resistance in pancreatic cancer: Impact of altered energy metabolismCritical Reviews in Oncology/Hematology 2017; 114: 139 doi: 10.1016/j.critrevonc.2017.03.026
3
Claudia Schmidt, Cornelia Loos, Lu Jin, Michael Schmiech, Christoph Q. Schmidt, Menna El Gaafary, Tatiana Syrovets, Thomas Simmet. Acetyl-lupeolic acid inhibits Akt signaling and induces apoptosis in chemoresistant prostate cancer cells in vitro and in vivoOncotarget 2017; 8(33): 55147 doi: 10.18632/oncotarget.19101
4
Liangliang Lei, Jianguang Wang, Like Zhang, Yanbin Chen, Pengfei Yuan, Dechun Liu. Meta-analysis of the clinical value of abnormally expressed long non-coding RNAs for pancreatic cancerOncotarget 2017; 8(51): 89149 doi: 10.18632/oncotarget.20803
5
Fengbiao Guo, Jinping Li, Yaozhi Qi, Jianqing Hou, Haibin Chen, Shi-Wen Jiang. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulationCancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01248-1
6
Jonas R.M. Van Audenaerde, Jorrit De Waele, Elly Marcq, Jinthe Van Loenhout, Eva Lion, Johan M.J. Van den Bergh, Ralf Jesenofsky, Atsushi Masamune, Geert Roeyen, Patrick Pauwels, Filip Lardon, Marc Peeters, Evelien L.J. Smits. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cellsOncotarget 2017; 8(34): 56968 doi: 10.18632/oncotarget.18185
7
Therese Triemer, Alessandra Messikommer, Stella M. K. Glasauer, Jawad Alzeer, Miriam H. Paulisch, Nathan W. Luedtke. Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanismProceedings of the National Academy of Sciences 2018; 115(7): E1366 doi: 10.1073/pnas.1714790115
8
Shuai Hu, Yi Jin, Yanghan Liu, Mats Ljungman, Nouri Neamati. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell linesEuropean Journal of Medicinal Chemistry 2018; 158: 884 doi: 10.1016/j.ejmech.2018.09.037
9
Fausto Petrelli, Alessandro Inno, Antonio Ghidini, Lorenza Rimassa, Gianluca Tomasello, Roberto Labianca, Sandro Barni. Second line with oxaliplatin- or irinotecan-based chemotherapy for gemcitabine-pretreated pancreatic cancer: A systematic reviewEuropean Journal of Cancer 2017; 81: 174 doi: 10.1016/j.ejca.2017.05.025
10
Patrick L. Quinn, Donald Ohioma, Anja M.K. Jones, Sushil K. Ahlawat, Ravi J. Chokshi. Treatment of Rare and Aggressive Pancreatic CarcinosarcomaACG Case Reports Journal 2020; 7(5): e00379 doi: 10.14309/crj.0000000000000379
11
Linas J. Krulikas, Ian M. McDonald, Benjamin Lee, Denis O. Okumu, Michael P. East, Thomas S. K. Gilbert, Laura E. Herring, Brian T. Golitz, Carrow I. Wells, Allison D. Axtman, William J. Zuercher, Timothy M. Willson, Dmitri Kireev, Jen Jen Yeh, Gary L. Johnson, Antonio T. Baines, Lee M. Graves. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthSLAS DISCOVERY: Advancing the Science of Drug Discovery 2018; 23(8): 850 doi: 10.1177/2472555218773045
12
Gui‐Feng Liu, Gui‐Jie Li, Hang Zhao. Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta‐AnalysisJournal of Cellular Biochemistry 2018; 119(1): 511 doi: 10.1002/jcb.26210
13
Xiu Hu, Wei Chen. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinomaWorld Journal of Clinical Cases 2021; 9(19): 4998-5006 doi: 10.12998/wjcc.v9.i19.4998